Clinical trial
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
NCT00350662 · Lipomed, Industry · Completed
Key facts
| NCT number | NCT00350662 |
|---|---|
| Title | Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients |
| Official title | Randomized Open-label Phase III Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients |
| Lead sponsor | Lipomed, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemochromatosis |
| Intervention type | Drug |
| Interventions | Deferiprone (L1), Desferrioxamine |
| Enrollment | 95 |
| Start date | Jan 1, 2002 |
| First posted | Jul 11, 2006 |
| Last update posted | Nov 19, 2012 |
| Countries | Egypt, Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: